Park Hotels & Resorts Inc. Common Stock vs Revvity Inc — how do they compare? Park Hotels & Resorts Inc. Common Stock trades at $15.28 (market cap $3.05B), while Revvity Inc trades at $155 (market cap $16.97B). The key difference: Revvity Inc is far larger — about 5.6× Park Hotels & Resorts Inc. Common Stock's market cap, and Park Hotels & Resorts Inc. Common Stock pays the higher dividend (6.6%). Which is the better fit depends on your goals — on Pluang, investors hold Park Hotels & Resorts Inc. Common Stock for 0 Days and Revvity Inc for 13 Days on average.
| PK | RVTY | |
|---|---|---|
Market Cap | $3.05B | $16.97B |
Volume | 3,540,056 | 1,602,713 |
Sector | Real Estate | Health |
52-Week High | $16.17 | $157.36 |
52-Week Low | $9.84 | $82.26 |
Typical Hold Time | 0 Days | 13 Days |
Enterprise Value | $6.89B | $19.29B |
Dividend Yield | 6.6% | 0.18% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $155.08, down 0.34% today but near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving average support. Recent earnings beats and a Zacks upgrade to Buy reflect positive momentum. The company launched a new Type 1 diabetes screening kit in Europe and announced the acquisition of Human Cell Design, expanding its metabolic disease research tools.
Outlook remains positive with revenue stability and margin pressures manageable. Investment opportunity lies in diagnostic growth and AI-driven demand, though premium valuation and China market risks warrant caution. The absence of sell ratings and strong institutional accumulation support a constructive view, but rich multiples require sustained earnings delivery for further upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Park Hotels & Resorts Inc. is a US lodging REIT, spun off from Hilton Worldwide in 2017, that owns a portfolio of premium-branded hotels and resorts in major urban, resort, and convention markets.
Read more on PK →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →